SEC Form 4 · accession 0001651844-16-000022
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Jul 18, 2016
Accepted (ET)
Jul 22, 2016 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jul 18, 2016 | P | 2,500 | $3.29 | A | 2,870,050 | D | |
| COMMON STOCK | Jul 18, 2016 | P | 2,500 | $3.27 | A | 2,872,550 | D | |
| COMMON STOCK | Jul 19, 2016 | P | 2,500 | $3.35 | A | 2,875,050 | D | |
| COMMON STOCK | Jul 20, 2016 | P | 2,500 | $3.41 | A | 2,877,550 | D | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST |
Table II — derivative securities
No Table II lines on this filing.